Type 2 Biomarkers and Eosinophil Activation in Severe Asthma and the Impact of Mepolizumab

被引：0
|
作者：
Howarth, P. [1 ]
Quirce, S. [2 ,3 ]
Papi, A. [4 ,5 ]
Israel, E. [6 ,7 ]
Mallett, S. [8 ]
Bates, S. [9 ]
Albers, F. C. [10 ]
Kwon, N. [11 ]
机构：
[1] GSK House, Global Med Franchise, Brentford, England
[2] Hosp La Paz Inst Hlth Res IdiPAZ, Dept Allergy, Madrid, Spain
[3] Inst Carlos III, CIBERES, Madrid, Spain
[4] Univ Ferrara, Dept Med Sci, Ferrara, Italy
[5] S Anna Univ Hosp, Ferrara, Italy
[6] Harvard Med Sch, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Asthma Res Ctr, 75 Francis St, Boston, MA 02115 USA
[8] GSK, Biostat, Stockley Pk, Uxbridge, Middx, England
[9] GSK, Resp Discovery Med, Stevenage, Herts, England
[10] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[11] GSK, Resp Med Franchise, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1275
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The impact of mepolizumab on the sputum level of eosinophil-derived protein in three cases of severe asthma
    Koya, Toshiyuki
    Kimura, Yosuke
    Hayashi, Masachika
    Hasegawa, Takashi
    Kikuchi, Toshiaki
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 639 - 641
  • [2] Impact of mepolizumab in severe asthma with nasal polyps
    Tinoco, Eduarda M.
    Gigante, Ana R.
    Fernandes, Ana L.
    Cabrita, Bruno
    Santa, Catia
    Sucena, Ines
    Martins, Sara
    Machado, Daniela
    Franco, Ines
    Ladeira, Ines
    Pascoal, Ivone
    Lima, Ricardo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma
    Shrimanker, R.
    Pavord, I. D.
    Price, R.
    Bradford, E. S.
    Keene, O. N.
    Yancey, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Blood Eosinophil Phenotype During Treatment With Mepolizumab in Patients With Severe Eosinophilic Asthma
    Sakai, C.
    Matsuyama, M.
    Nakajima, M.
    Matsumura, S.
    Nonaka, M.
    Arai, N.
    Kuramoto, K.
    Yoshida, K.
    Morishima, Y.
    Muratani, M.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
    Howarth, Peter
    Quirce, Santiago
    Papi, Alberto
    Israel, Elliot
    Mallett, Stephen
    Bates, Stewart
    Yancey, Steve
    Albers, Frank C.
    Kwon, Namhee
    ALLERGY, 2020, 75 (08) : 2085 - +
  • [6] Burden Of Disease In Severe Asthma Mepolizumab Population Stratified By Blood Eosinophil Count
    Bradford, E.
    Follows, R.
    Price, R.
    Yancey, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
    Sakai, Chio
    Matsuyama, Masashi
    Nakajima, Masayuki
    Matsumura, Sosuke
    Nonaka, Mizu
    Arai, Naoki
    Kuramoto, Kenya
    Yoshida, Kazufumi
    Morishima, Yuko
    Muratani, Masafumi
    Hizawa, Nobuyuki
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (03) : 473 - 476
  • [8] Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma
    Taille, C.
    Hamidi, F.
    Heddebaut, N.
    Dupin, C.
    Le Guen, P.
    Le Brun, M.
    Pote, N.
    Cazes, A.
    Roy, C.
    Dupont, A.
    Letuve, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [9] Impact of age on the efficacy of mepolizumab in severe uncontrolled asthma
    Gonzalez Barcala, Francisco-Javier
    Blanco-Aparicio, Marina
    Nieto-Fontarigo, Juan-Jose
    Blanco-Cid, Nagore
    Gonzalez-Fernandez, Coral
    Mosteiro-Anon, Mar
    Calvo-Alvarez, Uxio
    Perez-De-Llano, Luis
    Corbacho-Abelaira, Maria-Dolores
    Dominguez-Juncal, Luis
    Crespo-Diz, Carlos
    Dacal-Quintas, Raquel
    Pallares-Sanmartin, Abel
    Dacal-Rivas, David
    Ruiz-Ferreras, Raquel
    Salgado, Francisco-Javier
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] GREATER EFFICACY OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA WITH HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Silver, J.
    Llanos, J.
    Mayer, B.
    Prazma, C.
    Albers, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S37 - S38
12345